Liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumors

Feng Dai,1,2 Xiuming Zhang,3 Wenrong Shen,3 Jun Chen,4 Liucheng Liu,5 Gejun Gao6 1The First College of Clinical Medicine, Nanjing University of Chinese Medicine, 2Department of Interventional Radiology, The Second Hospital of Nanjing, Medical School, Southeast University, 3Department of Rad...

Full description

Bibliographic Details
Main Authors: Dai F, Zhang XM, Shen WR, Chen J, Liu LC, Gao GJ
Format: Article
Language:English
Published: Dove Medical Press 2015-09-01
Series:OncoTargets and Therapy
Online Access:https://www.dovepress.com/liposomal-curcumin-inhibits-hypoxia-induced-angiogenesis-after-transca-peer-reviewed-article-OTT
id doaj-febd366a4f2a4be0898f12ec58ac442d
record_format Article
spelling doaj-febd366a4f2a4be0898f12ec58ac442d2020-11-24T22:59:57ZengDove Medical PressOncoTargets and Therapy1178-69302015-09-012015default2601261123668Liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumorsDai FZhang XMShen WRChen JLiu LCGao GJFeng Dai,1,2 Xiuming Zhang,3 Wenrong Shen,3 Jun Chen,4 Liucheng Liu,5 Gejun Gao6 1The First College of Clinical Medicine, Nanjing University of Chinese Medicine, 2Department of Interventional Radiology, The Second Hospital of Nanjing, Medical School, Southeast University, 3Department of Radiology, 4Department of Interventional Radiology, Jiangsu Province Tumor Hospital, 5Department of Pharmacy, Jiangsu Aosakang Pharmaceutical Co. Ltd, 6Department of Radiology, Jiangsu Province Hospital of TCM, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of China Purpose: The purpose of the study is to investigate the inhibition of hypoxia-induced angiogenesis after embolization in VX2 rabbit liver tumors by liposomal curcumin.Materials and methods: A total of 54 VX2 rabbits were divided into three groups, and each group had three subgroups according to the sacrifice time. The animals in the control group (n=18) underwent sham embolization. Transcatheter arterial embolization (TAE)-treated group (n=18) animals underwent embolization with lipiodol (0.1 mL/kg body weight) and 90–180 µm polyvinyl alcohol (PVA) particles. Liposomal curcumin TAE-treated group (n=18) animals underwent embolization with liposomal curcumin (20 mg/kg body weight) mixed with lipiodol (0.1 mL/kg body weight) and 90–180 µm PVA particles. After embolization, the animals in each subgroup were sacrificed at 6 hours, 24 hours, and 3 days, and the tumor samples were collected. Immunohistochemical staining was performed to evaluate expression of hypoxia-inducible factor-1α (HIF-1α) and vascular endothelial growth factor (VEGF) proteins, and microvessel density (MVD). Real-time polymerase chain reaction was performed to examine VEGF mRNA levels.Results: The levels of HIF-1α and VEGF, and MVD in tumors of liposomal curcumin TAE-treated group were significantly decreased compared to the TAE-treated group (P<0.05). There was a slight decrease in tumor size in the liposomal curcumin TAE-treated group at third-day time points compared to the TAE-treated group; the difference was not statistically significant (P>0.05). The HIF-1α protein correlated considerably with VEGF mRNA (r=0.705, P=0.001) and protein (r=0.655, P=0.003), and MVD (r=0.521, P=0.027). A significant correlation between VEGF protein and MVD was noted as well (r=0.519, P=0.027).Conclusion: Liposomal curcumin downregulates HIF-1α protein levels and inhibits hypoxia-induced angiogenesis after embolization in VX2 rabbit liver tumors.Keywords: hypoxia-inducible factor-1α, angiogenesis, embolization, liver tumorhttps://www.dovepress.com/liposomal-curcumin-inhibits-hypoxia-induced-angiogenesis-after-transca-peer-reviewed-article-OTT
collection DOAJ
language English
format Article
sources DOAJ
author Dai F
Zhang XM
Shen WR
Chen J
Liu LC
Gao GJ
spellingShingle Dai F
Zhang XM
Shen WR
Chen J
Liu LC
Gao GJ
Liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumors
OncoTargets and Therapy
author_facet Dai F
Zhang XM
Shen WR
Chen J
Liu LC
Gao GJ
author_sort Dai F
title Liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumors
title_short Liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumors
title_full Liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumors
title_fullStr Liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumors
title_full_unstemmed Liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumors
title_sort liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in vx2 rabbit liver tumors
publisher Dove Medical Press
series OncoTargets and Therapy
issn 1178-6930
publishDate 2015-09-01
description Feng Dai,1,2 Xiuming Zhang,3 Wenrong Shen,3 Jun Chen,4 Liucheng Liu,5 Gejun Gao6 1The First College of Clinical Medicine, Nanjing University of Chinese Medicine, 2Department of Interventional Radiology, The Second Hospital of Nanjing, Medical School, Southeast University, 3Department of Radiology, 4Department of Interventional Radiology, Jiangsu Province Tumor Hospital, 5Department of Pharmacy, Jiangsu Aosakang Pharmaceutical Co. Ltd, 6Department of Radiology, Jiangsu Province Hospital of TCM, Nanjing University of Chinese Medicine, Nanjing, People’s Republic of China Purpose: The purpose of the study is to investigate the inhibition of hypoxia-induced angiogenesis after embolization in VX2 rabbit liver tumors by liposomal curcumin.Materials and methods: A total of 54 VX2 rabbits were divided into three groups, and each group had three subgroups according to the sacrifice time. The animals in the control group (n=18) underwent sham embolization. Transcatheter arterial embolization (TAE)-treated group (n=18) animals underwent embolization with lipiodol (0.1 mL/kg body weight) and 90–180 µm polyvinyl alcohol (PVA) particles. Liposomal curcumin TAE-treated group (n=18) animals underwent embolization with liposomal curcumin (20 mg/kg body weight) mixed with lipiodol (0.1 mL/kg body weight) and 90–180 µm PVA particles. After embolization, the animals in each subgroup were sacrificed at 6 hours, 24 hours, and 3 days, and the tumor samples were collected. Immunohistochemical staining was performed to evaluate expression of hypoxia-inducible factor-1α (HIF-1α) and vascular endothelial growth factor (VEGF) proteins, and microvessel density (MVD). Real-time polymerase chain reaction was performed to examine VEGF mRNA levels.Results: The levels of HIF-1α and VEGF, and MVD in tumors of liposomal curcumin TAE-treated group were significantly decreased compared to the TAE-treated group (P<0.05). There was a slight decrease in tumor size in the liposomal curcumin TAE-treated group at third-day time points compared to the TAE-treated group; the difference was not statistically significant (P>0.05). The HIF-1α protein correlated considerably with VEGF mRNA (r=0.705, P=0.001) and protein (r=0.655, P=0.003), and MVD (r=0.521, P=0.027). A significant correlation between VEGF protein and MVD was noted as well (r=0.519, P=0.027).Conclusion: Liposomal curcumin downregulates HIF-1α protein levels and inhibits hypoxia-induced angiogenesis after embolization in VX2 rabbit liver tumors.Keywords: hypoxia-inducible factor-1α, angiogenesis, embolization, liver tumor
url https://www.dovepress.com/liposomal-curcumin-inhibits-hypoxia-induced-angiogenesis-after-transca-peer-reviewed-article-OTT
work_keys_str_mv AT daif liposomalcurcumininhibitshypoxiainducedangiogenesisaftertranscatheterarterialembolizationinvx2rabbitlivertumors
AT zhangxm liposomalcurcumininhibitshypoxiainducedangiogenesisaftertranscatheterarterialembolizationinvx2rabbitlivertumors
AT shenwr liposomalcurcumininhibitshypoxiainducedangiogenesisaftertranscatheterarterialembolizationinvx2rabbitlivertumors
AT chenj liposomalcurcumininhibitshypoxiainducedangiogenesisaftertranscatheterarterialembolizationinvx2rabbitlivertumors
AT liulc liposomalcurcumininhibitshypoxiainducedangiogenesisaftertranscatheterarterialembolizationinvx2rabbitlivertumors
AT gaogj liposomalcurcumininhibitshypoxiainducedangiogenesisaftertranscatheterarterialembolizationinvx2rabbitlivertumors
_version_ 1725643087366062080